We are live on ! Find out more
BC

Blackcrane Capital Portfolio holdings

AUM $16.3M
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
-19.53%
3 Year Est. Return
+40.04%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72M
AUM Growth
-$6.44M
Cap. Flow
-$1.59M
Cap. Flow %
-2.21%
Top 10 Hldgs %
96.83%
Holding
16
New
2
Increased
6
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
PROF
Profound Medical
PROF
+$2.72M
2
VTEX icon
VTEX
VTEX
+$1.01M
3
ARCE
Arco Platform Limited Class A Common Shares
ARCE
+$813K
4
WIX icon
WIX.com
WIX
+$569K
5
RCEL icon
Avita Medical
RCEL
+$316K

Top Sells

Rank Stock Value
1
OTEX icon
Open Text
OTEX
+$2.99M
2
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$2.47M
3
FERG icon
Ferguson
FERG
+$1.11M
4
CLPT icon
ClearPoint Neuro
CLPT
+$512K
5
BABA icon
Alibaba
BABA
+$242K

Sector Composition

Rank Sector Weight
1 Healthcare 35.05%
2 Technology 34.01%
3 Industrials 22.35%
4 Financials 6.38%
5 Consumer Staples 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FERG icon
1
Ferguson
FERG
$45B
$16.1M 22.35%
90,780
-7,056
-7% -$1.11M
NICE icon
2
Nice
NICE
$5.87B
$12.6M 17.55%
41,638
-12
-0% -$3.46K
PROF
3
Profound Medical
PROF
$249M
$11.3M 15.64%
1,001,643
+217,988
+28% +$2.72M
WIX icon
4
WIX.com
WIX
$2.15B
$9.54M 13.25%
60,478
+3,279
+6% +$569K
RCEL icon
5
Avita Medical
RCEL
$157M
$5.45M 7.57%
454,871
+20,700
+5% +$316K
HDB icon
6
HDFC Bank
HDB
$135B
$4.6M 6.38%
141,260
– –
TAK icon
7
Takeda Pharmaceutical
TAK
$54.8B
$3.75M 5.2%
31,138
+2,860
+10% +$40.1K
AXNX
8
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.62M 3.63%
46,716
+1,617
+4% +$98.8K
MYOV
9
DELISTED
Myovant Sciences Ltd.
MYOV
$2.17M 3.02%
139,552
+8,458
+6% +$161K
MSFT icon
10
Microsoft
MSFT
$2.93T
$1.62M 2.25%
4,826
– –
ARCE
11
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$875K 1.21%
+41,886
New +$813K
BABA icon
12
Alibaba
BABA
$276B
$718K 1%
6,047
-1,663
-22% -$242K
VTEX icon
13
VTEX
VTEX
$716M
$689K 0.96%
+64,232
New +$1.01M
AUPH icon
14
Aurinia Pharmaceuticals
AUPH
$2.05B
– –
-111,608
Closed -$2.47M
CLPT icon
15
ClearPoint Neuro
CLPT
$454M
– –
-28,817
Closed -$512K
OTEX icon
16
Open Text
OTEX
$5.65B
– –
-61,240
Closed -$2.99M

Similar funds

FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM

Blackcrane Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Blackcrane Capital held 16 positions worth $72M, down 8.2% from $78.5M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Blackcrane Capital's Q4 2021 filing shows 2 new, 6 increased, 3 reduced and 3 closed positions. Its largest new stake was VTEX: 64,232 shares worth $689K. The largest sale was Open Text, an estimated $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 40% a quarter earlier, followed by Technology and Industrials.

  • Blackcrane Capital's largest Q4 2021 buy was VTEX: 64,232 shares worth $689K.
  • Blackcrane Capital added most to Profound Medical in Q4 2021, an estimated $2.72M increase.
  • Blackcrane Capital's biggest Q4 2021 reduction was Ferguson, cutting an estimated $1.11M.
  • Blackcrane Capital fully exited Open Text in Q4 2021, selling an estimated $2.99M.
  • Blackcrane Capital's ten largest holdings make up 97% of its $72M portfolio in Q4 2021.
  • Blackcrane Capital opened 2 new positions and closed 3 in Q4 2021.
  • Blackcrane Capital's portfolio value fell 8.2% quarter-over-quarter to $72M.

Based on Blackcrane Capital's 13F filing for Q4 2021, filed 14 Feb 2022.